Technology platform

Technology platform

Scientist advisory team

Scientist advisory team

Zhou Qilin

Zhou Qilin

Academician of Chinese Academy of Sciences

Zhou Qilin

● Professor, Nankai University

● Expert in chiral catalysis

Focus on asymmetric catalysis, including the design and synthesis of novel chiral ligands and chiral catalysts, the development of new asymmetric catalytic reactions, and chiral drug synthesis

● The project "Discovery of Highly efficient chiral spiral catalyst" won the first prize of the National Natural Science Award

Ma Dawei

Ma Dawei

Academician of Chinese Academy of Sciences

Ma Dawei

● Researcher, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences

● Mainly studies the total synthesis of complex natural products with important physiological activities, organic synthesis methodology, etc

俞飚

俞飚

Academician of Chinese Academy of Sciences

俞飚

● Director of the State Key Laboratory of Biological Organic Chemistry

● Expert in sugar chemistry

● The research direction is complex oligosaccharides, glycoconjugates and other natural products with important physiological activities

● Whistler Prize in Sugar Chemistry 2022 (the first Chinese scholar to win the prize)

Wang Guangji

Wang Guangji

Academician, Chinese Academy of Engineering

Wang Guangji

● Expert in pharmacokinetics

● Mainly engaged in pharmacology, pharmacokinetics and toxicology research

Hu Jinbo

Hu Jinbo

President, Shanghai Branch, Chinese Academy of Sciences

Hu Jinbo

● Expert in fluorine chemistry

● Focus on the research of new reagents and new reactions in fluorine chemistry

李昂

李昂

Deputy Director, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences

李昂

● Deputy Director of the State Key Laboratory of Biological Organic Chemistry

● Experts in the field of full synthesis

● Focus on chemical synthesis of active natural products

Tang Wenjun

Tang Wenjun

Researcher, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences

Tang Wenjun

● Asymmetric catalytic reaction expert

● Focus on asymmetric catalysis and drug process research

Andreas Flueckiger

Andreas Flueckiger

Occupational safety and health experts

Andreas Flueckiger

● Former Global Head of Occupational Health and Toxicology at Roche Pharmaceuticals

● Extensive expertise in occupational health assessment and EHS audit

Core research team

Core research team

Che Daqing

Che Daqing

PhD, University of Marburg, Germany

Che Daqing

● Postdoctoral Fellow, University of Calgary, Canada

● High-level talents in Zhejiang Province

● Published more than 20 SCI articles in international journals

● Focus on small molecule drug development and green chemical process development and application, with 30 years of organic synthesis and drug synthesis experience。He is responsible for the successful development of more than 30 API green synthesis process routes and more than 2,000 small molecule compounds, and has undertaken a number of national and provincial major scientific research projects

Li Yuanqiang

Li Yuanqiang

PhD, Kyushu University, Japan

Li Yuanqiang

● Postdoctoral Fellow at Columbia University

● Zhejiang Province high-level talents, "Zhejiang Province leading innovation team" main leader

● Professor level senior engineer

● Has more than 20 years of rich experience in the research and development and production of chemical apis, especially in the field of green synthesis technology (such as chiral catalysis, fluorine chemistry, continuous reaction and enzyme catalysis) technology development and industrial application has made remarkable achievements

Yin Lifang

Yin Lifang

Doctor, China Pharmaceutical University

Yin Lifang

● Postdoctoral Fellow, Peking University

● Professor and doctoral supervisor of China Pharmaceutical University

● External evaluation experts of the Drug Evaluation Center of the State Drug Administration

● Published more than 40 papers in SCI journals

● Won the first prize of Jiangsu Science and Technology Progress Award

● Engaged in pharmaceutical preparations and their quality research, pharmacokinetic research for nearly 30 years, long-term commitment to new dosage forms and new technology related research, to solve the problem of preparation industrialization and its standard determination

陈功

陈功

Ph.D., Sun Yat-sen University

陈功

● Shanghai Youth Science and technology star, Taizhou City "500 Elite Plan" innovative talent

● Published 10 SCI papers and applied for 7 patents

● More than 20 years of experience in drug development and production management, and participated in the process safety assessment of more than 500 production scale-up projects

Peter Newsome

Peter Newsome

PhD in chemistry, University of Utah

Peter Newsome

● Won the Rhone-Planck Research Award and the Silver Orchid Excellence Award

● Focus on the research of new reagents and new reactions in fluorine chemistry

Strict census

Strict census

Doctor from Nankai University

Strict census

● 151 talents in Zhejiang Province

● Mainly studies the total synthesis of complex natural products with important physiological activities, organic synthesis methodology, etc

David A. Perrey

David A. Perrey

PhD, University of St Andrews

David A. Perrey

● Postdoctoral Fellow, Georgia Institute of Technology

● As head of Ruibo's US synthesis team, responsible for several projects including preclinical discovery, process development and low-volume production

徐峰

徐峰

Doctor, Zhejiang University of Technology

徐峰

● Innovative talents of Taizhou "500 Elite Plan"

● Published 5 SCI papers in international journals

● Have rich experience in customizing customer peptides, and presided over and participated in more than 10 FDA and CFDA registration projects, including peptide apis, freeze-dried powder injections, etc

Matthew G. Lauer

Matthew G. Lauer

PhD, Ohio State University

Matthew G. Lauer

● Postdoctoral Fellow, University of Alabama

● Focus on the synthesis route development, synthesis, separation and other research of organic and organometallic compounds, with rich experience in the development and optimization of new chemical reactions

Xu Tinghua

Xu Tinghua

Ph.D. from Jilin University

Xu Tinghua

● Post-doctoral fellow in Metal organocatalytics, Kyoto University, Japan

● Innovative talents of Taizhou "500 Elite Plan"

● More than 10 years of CDMO chemical customization service, API process development and production experience

Li Yonggang

Li Yonggang

Doctor, East China University of Science and Technology

Li Yonggang

● MBA from BI Business School, Fudan University, Norway

● Published 6 SCI articles in international journals

● Focus on API process development, with 20 years of experience in organic synthesis and process development, has completed more than 60 API process development projects and undertaken a number of city-level scientific research projects

于帅

于帅

PhD, Seoul National University, Korea

于帅

● Postdoctoral Fellow, City University of New York, USA

● In Organic Letters, Published articles as first author in international journals such as The Journal of Organic Chemistry and ACS Medicinal Chemistry Letters

● More than 10 years of working experience in the field of total synthesis of natural products, small molecule drug development and API process development。Responsible for the successful development of more than 10 API synthesis process routes and hundreds of small molecule compounds